Precipio (NASDAQ:PRPO) Share Price Crosses Above 200-Day Moving Average – Should You Sell?

Precipio, Inc. (NASDAQ:PRPO) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.30 and traded as high as $10.74. Precipio shares last traded at $10.14, with a volume of 77,637 shares traded.

Precipio Stock Performance

The company has a current ratio of 0.73, a quick ratio of 0.60 and a debt-to-equity ratio of 0.02. The firm’s 50-day moving average is $6.42 and its two-hundred day moving average is $6.31. The stock has a market cap of $15.03 million, a price-to-earnings ratio of -5.54 and a beta of 1.42.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Precipio stock. Renaissance Technologies LLC purchased a new stake in Precipio, Inc. (NASDAQ:PRPO) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 10,100 shares of the biotechnology company’s stock, valued at approximately $56,000. Renaissance Technologies LLC owned 0.68% of Precipio at the end of the most recent reporting period. Hedge funds and other institutional investors own 10.45% of the company’s stock.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.